Supply Chain Update

IEEE Releases First Study of Blockchain Adoption in the Pharmaceutical Industry

Most pharma supply chain partners believe that manufacturers should pay for blockchain implementations, and own the data.
/ read more /

Temperature-Controlled Shipping Service Solution

lmac Group's Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, is available in the United States.
/ read more /

MediLedger to Explore Use of Blockchain for DSCSA Compliance

Genentech, AmerisourceBergen, and McKesson are providing pharma user requirements for a new project that will evaluate blockchain's potential in meeting requirements of the Drug Supply Chain Security Act, and preventing pharmaceutical counterfeiting.
/ read more /

Virgin Atlantic Cargo, Delta Cargo Unveil New Pharma Zone

Virgin Atlantic Cargo and Delta Cargo have opened a new Pharma Zone at their joint facility at London Heathrow Airport for the handling and storage of pharmaceutical shipments.
/ read more /

Real-Time Logistics

Internet of things, advanced analytics, and blockchain solutions such as smart contracts promise to give manufacturers more control over products and supply chains.
/ read more /

Flying Warehouse for Temperature-Sensitive Air Cargo

DoKaSch Temperature Solutions, a Germany-based provider of climate-controlled air cargo containers, announced that its Opticooler air cargo containers are now available in the United States.
/ read more /

API Synthesis & Manufacturing

Setting Safety Processes for Potentially Potent APIs

CDMOs sharpen skills for identifying API potency risks and establishing safety and handling procedures.
/ read more /

Outsourcing Update

A Potential Downside to the CDMO M&A Frenzy

Investors are betting on the current growth of CDMOs; but history reminds us that extrapolating today's market well into the future is dangerous.
/ read more /

CPhI Annual Report Highlights Unpredictability in CDMO Growth Over Next Five Years

Predicted areas of growth include flow chemistry, fermentation, repatriation of overseas funds, oncology, and API/product integration, but the rate of change is unclear.
/ read more /

In the Lab

Early Efforts Identify Unstable APIs

Forced degradation tests, conducted in early development stages, can provide insight into degradation pathways and products of a drug substance.
/ read more /

Contract Services Update

CordenPharma Invests in Small Molecule API Development Capacity

CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site.
/ read more /

Piramal Plans Large-Scale Expansion of API Manufacturing Facilities

Piramal is investing $55 million into the expansion of its API manufacturing capabilities and capacities across sites in North America and Asia.
/ read more /

Cambrex Invests in Generic API Development and Manufacturing Capabilities at its Milan Site

Investments include the installation of development and analytical equipment to support the development of highly potent APIs as well as a new 2800-liter hydrogenator and 1500-mm diameter centrifuge for increased flexibility and capacity within the manufacturing plant.
/ read more /

Lonza to Acquire Manufacturing Facility from Shire

Lonza has announced plans to acquire a clinical-stage mammalian manufacturing facility in the United States from Shire.
/ read more /

PCI Pharma Services to Acquire Millmount Healthcare

PCI Pharma Services, a pharmaceutical outsourcing services provider, will acquire Millmount Healthcare, a pharmaceutical and healthcare contract packaging services provider, to expand its European services.
/ read more /